Results 21 to 30 of about 16,224,526 (223)

Awake versus intubated video-assisted thoracoscopic surgery for pleural disease: a retrospective cohort study from a single tertiary center [PDF]

open access: yesFrontiers in Surgery
IntroductionAwake video-assisted thoracoscopic surgery (A-VATS) has gained increasing attention as an alternative to classical intubated VATS (I-VATS), particularly in patients with comorbidities that have increased the risk of surgery under general ...
Omer Faruk Saglam   +7 more
doaj   +2 more sources

Intrapleural interleukin-2–expressing oncolytic virotherapy enhances acute antitumor effects and T-cell receptor diversity in malignant pleural disease [PDF]

open access: yesJ Thorac Cardiovasc Surg, 2020
Objective: The mainstay of treatment for patients with malignant pleural disease is fluid drainage and systemic therapy. A tumor-specific oncolytic virus or T-cell–activating interleukin-2 immunotherapy may provide an opportunity for local control.
Chigozirim N. Ekeke   +8 more
semanticscholar   +2 more sources

Advances in pleural disease [PDF]

open access: yesEuropean Respiratory Review, 2016
This editorial provides an update on pleural research and aims to highlight the areas that will be covered in the review series http://ow.ly ...
Psallidas, I, Rahman, N
openaire   +5 more sources

Diagnostic Utility of Pleural Fluid Cell Block versus Pleural Biopsy Collected by Flex-Rigid Pleuroscopy for Malignant Pleural Disease: A Single Center Retrospective Analysis. [PDF]

open access: yesPLoS ONE, 2016
Some trials recently demonstrated the benefit of targeted treatment for malignant disease; therefore, adequate tissues are needed to detect the targeted gene.
Shion Miyoshi   +4 more
doaj   +2 more sources

Research priorities in pleural disease: study protocol for a joint patient–provider Delphi consensus statement [PDF]

open access: yesBMJ Open Respiratory Research
Introduction There is a wide global variation in research priorities and current clinical practise among pleural medicine practitioners. Research performed today will inform future clinical practice, but the patient’s voices are often not heard in ...
Uffe Bodtger   +4 more
doaj   +2 more sources

Malignant pleural disease

open access: yesEuropean Journal of Radiology, 2000
The vast majority of pleural neoplasms invade the pleura secondarily and can be seen in patients with bronchogenic carcinoma, breast cancer, lymphoma, and ovarian or gastric carcinoma. Primary pleural neoplasms are less common, although they have developed notoriety since the up-surge of malignant mesothelioma and the knowledge of its connection to ...
BONOMO, Lorenzo   +4 more
openaire   +4 more sources

IgG4‐related pleural disease diagnosed by thoracoscopic pleural biopsy: A case report [PDF]

open access: yesRespirology Case Reports
Here we report a rare case of immunoglobulin G4 (IgG4)–related pleural disease diagnosed using a thoracoscopic pleural biopsy. A 66‐year‐old man was admitted to our hospital with right‐dominant bilateral pleural effusions and gradually worsening dyspnoea.
Azusa Miyoshi   +4 more
doaj   +2 more sources

Unexpandable lung from pleural disease

open access: yesRespirology (Carlton South. Print), 2018
Unexpandable lung is a common complication of malignant pleural effusions and inflammatory pleural diseases, such as pleural infection (e.g. empyema and complicated parapneumonic effusion) and noninfectious fibrinous pleuritis.
J. Huggins   +4 more
semanticscholar   +2 more sources

British Thoracic Society Guideline for pleural disease

open access: yesThorax, 2023
pleural effusion treated with indwelling pleural catheters, do intrapleural agents (talc or other pleurodesis agents) improve clinical outcomes?
M. Roberts   +21 more
semanticscholar   +2 more sources

Staging by Thoracoscopy in potentially radically treatable Lung Cancer associated with Minimal Pleural Effusion (STRATIFY): protocol of a prospective, multicentre, observational study

open access: yesBMJ Open Respiratory Research, 2023
Introduction Recurrence rate following radical therapy for lung cancer remains high, potentially reflecting occult metastatic disease, and better staging tools are required.
Selina Tsim   +18 more
doaj   +1 more source

Home - About - Disclaimer - Privacy